Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1

Published:2020-07-29 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Yang Yong,Wang Yong,He Zuowen,Liu Yunchang,Chen Chen,Wang Yan,Wang Dao Wen,Wang Hong

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference75 articles.

1. NAD+ metabolism in health and disease;Belenky;Trends Biochem. Sci.,2007

2. Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells;Benito-Martin;Biochim. Biophys. Acta,2014

3. Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation;Bugyei-Twum;Cardiovasc. Res.,2018

4. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity;Canto;Nature,2009

5. Natural products with anti-aging potential: Affected targets and molecular mechanisms;Catana;Biotechnol. Adv.,2018

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Fibrosis: SIRT1 Still of Value;Biomedicines;2024-08-23

2. (+)‐Catechins Play a Protective Role in Diabetic Kidney Disease by Alleviating EMT through Multiple Pathways;Molecular Nutrition & Food Research;2024-08-09

3. Roles of Sirt1 and its modulators in diabetic microangiopathy: A review;International Journal of Biological Macromolecules;2024-04

4. Resveratrol Inhibits Restenosis through Suppressing Proliferation, Migration and Trans-differentiation of Vascular Adventitia Fibroblasts via Activating SIRT1;Current Medicinal Chemistry;2024-01

5. Role of SIRT-1 as a Target for Treatment and Prevention of Diabetic Nephropathy: A Review;Current Molecular Pharmacology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3